Investor: David Goel
Number of Assets: 4
Reported Holdings: $347,213,639
Reporting Period: Q1 - 2025
Return Since Report: -$1,054,726
Return Since Report: -0.30%
Company | Position | Activity | Shares | Port. % | Rep. Price | Curr. Price | Rep. Value | Curr. Value | Return Value | Return % |
|---|---|---|---|---|---|---|---|---|---|---|
| Aura Biosciences Inc. (AURA) | Equity | 0% | 6,922,870 | 11.68% | $5.86 | $5.26 | $40,568,018 | $36,414,296 | -$4,153,722 | -10.24% |
| Maze Therapeutics Inc. (MAZE) | Equity | +100% | 2,486,184 | 7.88% | $11.01 | $13.66 | $27,372,886 | $33,961,273 | +$6,588,387 | +24.07% |
| Globalfoundries Inc. (GFS) | Equity | -51.17% | 6,964,952 | 74.04% | $36.91 | $36.87 | $257,076,378 | $256,797,780 | -$278,598 | -0.11% |
| Zentalis Pharmaceuticals Inc. (ZNTL) | Equity | 0% | 13,959,973 | 6.39% | $1.59 | $1.36 | $22,196,357 | $18,985,563 | -$3,210,794 | -14.47% |